Review an interactive resource summarizing data from an ongoing Phase 3 clinical study evaluating the long-term efficacy and safety profile of an oral therapy for the treatment of patients with moderate-to-severe #AtopicDermatitis (AD). View the results of this planned interim analysis here: https://lnkd.in/eAWVupuJ
